Pei-Shan Ho Selected Research

Pei-Shan Ho Research Topics

3	Periodontal Diseases (Periodontal Disease) 01/2023 - 05/2017
3	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2020
2	Opioid-Related Disorders (Opiate Addiction) 01/2023 - 01/2021
2	Neoplasms (Cancer) 12/2012 - 07/2011
2	Carcinoma (Carcinomatosis) 10/2008 - 06/2007
1	Hip Fractures (Intertrochanteric Fractures) 01/2023
1	Dyslipidemias (Dyslipidemia) 01/2023
1	Serotonin Syndrome (Syndrome, Serotonin) 01/2023
1	Osteoporosis 01/2023
1	Hypokalemia 01/2023
1	Osteoporotic Fractures 01/2020
1	Peptic Ulcer (Peptic Ulcers) 01/2020
1	Schizophrenia (Dementia Praecox) 09/2019
1	Xerostomia 09/2019
1	Peritonitis 09/2013
1	Colorectal Neoplasms (Colorectal Cancer) 12/2012
1	Squamous Cell Carcinoma of Head and Neck 07/2011
1	Asthma (Bronchial Asthma) 12/2010
1	Mouth Neoplasms (Oral Cancer) 10/2008

2	Methadone (Dolophine)FDA LinkGeneric 01/2023 - 01/2021
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2012 - 10/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2021
1	AcidsIBA 01/2020
1	Proton Pump InhibitorsIBA 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 09/2019
1	Antipsychotic Agents (Antipsychotics)IBA 09/2019
1	Cholinergic Antagonists (Anticholinergics)IBA 09/2019
1	4-O-carboxymethylascochlorinIBA 12/2012
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2012
1	Retinoic Acid 4-Hydroxylase (CYP26B1)IBA 07/2011
1	MetalsIBA 12/2010
1	Immunoglobulin E (IgE)IBA 12/2010
1	Arecoline (Arecolin)IBA 10/2008
1	Messenger RNA (mRNA)IBA 10/2008

3	Therapeutics 01/2023 - 06/2007
1	Patient Readmission 01/2023
1	Dental Care 01/2023
1	Glycemic Control 01/2020
1	Drug Therapy (Chemotherapy) 09/2019
1	Oral Hygiene (Dental Hygiene) 09/2019
1	Dental Occlusion 05/2017
1	Oral Diagnosis (Oral Examination) 05/2017
1	Peritoneal Dialysis 09/2013
1	Chemoprevention 12/2012